Madge K. Shafmaster's most recent trade in ProMIS Neurosciences Inc. was a trade of 20,000 Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc. | Madge K. Shafmaster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc. | Madge K. Shafmaster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc. | Madge K. Shafmaster | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 20 Sep 2024 | 70,000 | 208,333 | - | 1.3 | 91,028 | Common Shares |
| ProMIS Neurosciences Inc. | Madge K. Shafmaster | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 20 Sep 2024 | 70,000 | 138,333 | - | 1.3 | 89,656 | Common Shares |
| ProMIS Neurosciences Inc. | Madge K. Shafmaster | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 20 Sep 2024 | 60,000 | 68,333 | - | 1.3 | 75,066 | Common Shares |